国际医药卫生导报2016，Vol.22Issue(20)：3132-3134,3.DOI:10.3760/cma.j.issn.1007-1245.2016.20.027
瑞舒伐他汀与阿托伐他汀治疗对急性冠脉综合征患者脂蛋白与炎性因子影响对比分析
Effects of rosuvastatin versus atorvastatin on lipoprotein and inflammatory factors in patients with acute coronary syndrome
韩文杰 1刘恒亮1
作者信息
- 1. 450000 郑州人民医院心血管内科二病区
- 折叠
摘要
Abstract
Objective To investigate the clinical effect and application value of rosuvastatin versus atorvastatin in the treatment of acute coronary syndrome.Methods The patients with acute coronary syndrome treated at our hospital were divided into two a control group and an observation group using random number table method.The control group were treated with atorvastatin and the observation group rosuvastatin.The treatment effects of both groups were recorded.Results After the treatment,the levels of total cholesterol,triglyceride,low density lipoprotein,high-sensitivity C-reactive protein,and IL-6 were (4.02 ± 0.37) mmol/L,(1.85 ± 0.13) mmol/ L,(2.46 ± 0.28) mmol/L,(3.11±0.52) mg/L,and (13.44 ± 235) μg/ml in the observation group,which were much better than those in the control group (P ＜ 0.05).Conclusions Rosuvastatin can effectively reduce the blood lipid and inflammatory levels in patients with acute coronary syndrome.关键词
瑞舒伐他汀/阿托伐他汀/急性冠脉综合征/脂蛋白/炎性因子Key words
Rosuvastatin/Atorvastatin/Acute coronary syndrome/Lipoprotein/Inflammatory factors引用本文复制引用
韩文杰,刘恒亮..瑞舒伐他汀与阿托伐他汀治疗对急性冠脉综合征患者脂蛋白与炎性因子影响对比分析[J].国际医药卫生导报,2016,22(20):3132-3134,3.
